PPIB and acute myeloid leukemia: Relatively, the adverse pathways were “pathogenic escherichia coli infection,” “apoptosis,” “acute myeloid leukemia,” “B cell receptor signaling pathway,” and “chronic myeloid leukemia” (Figure 7F).